---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-004172"
form_type: "8-K"
ticker: "OSCR"
cik: "0001568651"
company_name: "Oscar Health, Inc."
filed_at: "2023-01-09T23:59:59+00:00"
generated_at: "2026-06-20T17:49:27.430447+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "low"
source: SEC EDGAR
---

# Oscar Health reaffirms FY2022 guidance, 2023 profitability target at JPM Conference

## Summary
- Reaffirms full-year 2022 guidance per Nov 8, 2022 press release.
- Reaffirms 2023 profitability target for InsuranceCo.
- Provides interim membership update from 2023 open enrollment.
- Presentation at 41st JPM Healthcare Conference on Jan 11, 2023.

## SEC filing metadata
- accession: 0001193125-23-004172
- form_type: 8-K
- ticker: OSCR
- cik: 0001568651
- company_name: Oscar Health, Inc.
- filed_at: 2023-01-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: low
- sec_items: 2.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1568651/000119312523004172/0001193125-23-004172-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1568651/000119312523004172/d418633d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-004172
- JSON: https://secwatch.observer/filing/0001193125-23-004172.json
- Plain text: https://secwatch.observer/filing/0001193125-23-004172.txt

## Key facts
- Earnings Releases
  Oscar Health, Inc. updated its full year 2022 guidance (reaffirmed).
  - Period: full year 2022
  - Guidance: reaffirmed
  - Result: guidance update
  source text: the Company will reaffirm the updated full year 2022 guidance that it provided in its financial results press release for the third quarter of 2022 dated November 8, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1568651/000119312523004172/0001193125-23-004172-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.